Accès ouvert
2026
article
OpenAlex
I. Ruscito, M. Marraffa, E. Palluzzi, A. Cefaliello et autres
Metastatic and recurrent cervical cancer remains associated with poor prognosis. The KEYNOTE-826 trial established a new standard of care combining the checkpoint inhibitor pembrolizumab with platinum-based chemotherapy, with or without bevacizumab. We evaluated the efficacy and tolerability of this combination in a …
it
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
A. Giustozzi, F. De Dominicis, T. Salgarello, M. Cocuzza et autres
Mirvetuximab soravtansine (MIRV) is an antibody-drug conjugate targeting folate receptor alpha (FRα), approved for the treatment of patients with FRα-positive platinum-resistant ovarian cancer. Ocular adverse events are common with MIRV and may require dose modifications. Real-world data on incidence, predictors and clinical …
it
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Gloria Marquina, A. Bergamini, Ulrika Joneborg, C. Lok et autres
Rare gynaecological tumours (RGTs) represent a highly heterogeneous group of malignancies, often with more limited clinical evidence and expertise in their management unevenly distributed across Europe. Evidence on optimal treatment is often limited, contributing to delayed diagnosis, suboptimal treatment, and unequal access …
es, it, se, nl, no, fr, gb, pl, fi, at, ro, be
(code pays fourni par la source)
Accès ouvert
2019
conference-abstract
OpenAlex
Innocenza Palaia, Violante Di Donato, Angela Musella, Ludovico Muzii et autres
it
(code pays fourni par la source)